Page last updated: 2024-08-26
syringaresinol and Autoimmune Diabetes
syringaresinol has been researched along with Autoimmune Diabetes in 1 studies
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors
Authors | Studies |
---|---|
An, J; Feng, L; Gao, Y; Li, D; Li, G; Li, J; Li, Y; Liu, J; Qi, Z; Xu, Y; Yang, J; Yang, L | 1 |
Other Studies
1 other study(ies) available for syringaresinol and Autoimmune Diabetes
Article | Year |
---|---|
Syringaresinol Protects against Type 1 Diabetic Cardiomyopathy by Alleviating Inflammation Responses, Cardiac Fibrosis, and Oxidative Stress.
Topics: Animals; Apoptosis; Cardiotonic Agents; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Cardiomyopathies; Fibrosis; Furans; Hyperglycemia; Kelch-Like ECH-Associated Protein 1; Lignans; Male; Mice, Inbred C57BL; Myocarditis; Myocytes, Cardiac; NF-E2-Related Factor 2; Oxidative Stress | 2020 |